{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:22:43Z","timestamp":1769739763200,"version":"3.49.0"},"reference-count":53,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1821,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1472-8206.2010.00867.x","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T13:37:05Z","timestamp":1283780225000},"page":"518-527","source":"Crossref","is-referenced-by-count":20,"title":["Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period"],"prefix":"10.1111","volume":"25","author":[{"given":"Hala Abou","family":"Hammoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Aymard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Lechat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Boccheciampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Riou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Aubrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,9,6]]},"reference":[{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003088-199733030-00005","article-title":"Pharmacokinetic optimisation of opioid treatment in acute pain therapy","volume":"33","author":"Upton","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.0265-0215.2000.00796.x","article-title":"Postoperative titration of intravenous morphine","volume":"18","author":"Aubrun","year":"2001","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00000542-200507000-00023","article-title":"Sex- and age-related differences in morphine requirements for postoperative pain relief","volume":"103","author":"Aubrun","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000542-200201000-00009","article-title":"Postoperative titration of intravenous morphine in the elderly patient","volume":"96","author":"Aubrun","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/0024-3205(91)90150-A","article-title":"Mu receptor binding of some commonly used opioids and their metabolites","volume":"48","author":"Chen","year":"1991","journal-title":"Life Sci."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00000542-200401000-00021","article-title":"Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences","volume":"100","author":"Romberg","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1067\/mcp.2003.5","article-title":"Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers","volume":"73","author":"Skarke","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB8|cit8","first-page":"351","article-title":"No contribution of morphine-6-glucuronide to clinical morphine effects after short-term administration","volume":"21","author":"Lotsch","year":"1998","journal-title":"Clin. Neuropharmacol."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00000542-200210000-00011","article-title":"Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?","volume":"97","author":"Lotsch","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/03602539608994011","article-title":"The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine","volume":"28","author":"Milne","year":"1996","journal-title":"Drug Metab. Rev."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1016\/0024-3205(94)00552-4","article-title":"The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex","volume":"54","author":"Bartlett","year":"1994","journal-title":"Life Sci."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0024-3205(99)00239-8","article-title":"Brain region-specific studies of the excitatory behavioral effects of morphine-3-glucuronide","volume":"65","author":"Halliday","year":"1999","journal-title":"Life Sci."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1440-1681.2000.03290.x","article-title":"Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites","volume":"27","author":"Smith","year":"2000","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0006-2952(97)00086-5","article-title":"Effect of prior morphine-3-glucuronide exposure on morphine disposition and antinociception","volume":"53","author":"Ouellet","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1067\/mcp.2000.111934","article-title":"Randomized placebo-controlled trial of the activity of the morphine glucuronides","volume":"68","author":"Penson","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/jps.1131","article-title":"Limited phase I study of morphine-3-glucuronide","volume":"90","author":"Penson","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0885-3924(02)00531-6","article-title":"Relationships among morphine metabolism, pain and side effects during long-term treatment: an update","volume":"25","author":"Andersen","year":"2003","journal-title":"J. Pain Symptom Manage."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1191\/0269216303pm658oa","article-title":"Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain","volume":"17","author":"Quigley","year":"2003","journal-title":"Palliat. Med."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1191\/0269216303pm835oa","article-title":"Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients","volume":"17","author":"Klepstad","year":"2003","journal-title":"Palliat. Med."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3959(97)00142-5","article-title":"Systematic review of factors affecting the ratios of morphine and its major metabolites","volume":"74","author":"Faura","year":"1998","journal-title":"Pain"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/J354v16n04_02","article-title":"Clinical pharmacokinetics of morphine","volume":"16","author":"Lugo","year":"2002","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB22|cit22","first-page":"445","article-title":"Management of postoperative pain in adults and children","volume":"17","author":"Consensus conference.","year":"1998","journal-title":"Ann. Fr. Anesth. R\u00e9anim."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1213\/00000539-199801000-00020","article-title":"The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale","volume":"86","author":"DeLoach","year":"1998","journal-title":"Anesth. Analg."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/00000542-200306000-00017","article-title":"Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration","volume":"98","author":"Aubrun","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/bmj.2.5920.656","article-title":"Controlled sedation with alphaxalone-alphadolone","volume":"2","author":"Ramsay","year":"1974","journal-title":"Br. Med. J."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00007691-199804000-00013","article-title":"Improved one-step solid-phase extraction method for morphine, morphine-3-glucuronide, and morphine-6-glucuronide from plasma and quantitation using high-performance liquid chromatography with electrochemical detection","volume":"20","author":"Wright","year":"1998","journal-title":"Ther. Drug Monit."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-4347(00)00146-8","article-title":"High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites by two-step solid-phase extraction","volume":"742","author":"Meng","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0731-7085(01)00393-4","article-title":"LC determination of morphine and morphine glucuronides in human plasma by coulometric and UV detection","volume":"26","author":"Ary","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00000542-200307000-00026","article-title":"Postoperative morphine consumption in the elderly patient","volume":"99","author":"Aubrun","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1990.2","article-title":"Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide","volume":"47","author":"Osborne","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00001503-200410000-00016","article-title":"Morphine metabolites as novel analgesic drugs?","volume":"17","author":"Lotsch","year":"2004","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jpainsymman.2005.01.004","article-title":"Opioid metabolites","volume":"29","author":"Lotsch","year":"2005","journal-title":"J. Pain Symptom Manage."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1007\/BF02854905","article-title":"Role of morphine\u2019s metabolites in analgesia: concepts and controversies","volume":"8","author":"Wittwer","year":"2006","journal-title":"AAPS J."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00228-008-0570-y","article-title":"Role of active metabolites in the use of opioids","volume":"65","author":"Coller","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(25)20113-6","article-title":"Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat","volume":"278","author":"Bickel","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000542-200112000-00009","article-title":"The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers","volume":"95","author":"Lotsch","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00228-007-0329-x","article-title":"Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery","volume":"63","author":"Dale","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/00000542-199712000-00014","article-title":"Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers","volume":"87","author":"Lotsch","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000542-200002000-00015","article-title":"Preemptive intravenous morphine-6-glucuronide is ineffective for postoperative pain relief","volume":"92","author":"Motamed","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1213\/01.ane.0000265557.73688.32","article-title":"Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites","volume":"105","author":"Mazoit","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/bja\/89.5.697","article-title":"Is morphine-induced sedation synonymous with analgesia during intravenous morphine titration?","volume":"89","author":"Paqueron","year":"2002","journal-title":"Br. J. Anaesth."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1213\/01.ane.0000281441.93304.e3","article-title":"Opioid-induced sedation in the postanesthesia care unit does not insure adequate pain relief: a case-control study","volume":"105","author":"Lentschener","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2125.1989.tb05401.x","article-title":"Long lasting respiratory depression induced by morphine-6-glucuronide?","volume":"27","author":"Hasselstrom","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0024-3205(94)90106-6","article-title":"Morphine-3-glucuronide: silent regulator of morphine actions","volume":"55","author":"Lipkowski","year":"1994","journal-title":"Life Sci."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/js980056f","article-title":"Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling","volume":"87","author":"Gardmark","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0885-3924(97)00020-1","article-title":"Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients","volume":"14","author":"Ashby","year":"1997","journal-title":"J. Pain Symptom Manage."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0304-3959(02)00422-0","article-title":"Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy","volume":"100","author":"Mao","year":"2002","journal-title":"Pain"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001756-200301200-00001","article-title":"Opioid-induced hyperalgesia: abnormal or normal pain?","volume":"14","author":"Simonnet","year":"2003","journal-title":"Neuroreport"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/neu.20091","article-title":"Antinociceptive and nociceptive actions of opioids","volume":"61","author":"Ossipov","year":"2004","journal-title":"J. Neurobiol."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pain.2005.06.006","article-title":"Is morphine-3-glucuronide of therapeutic relevance?","volume":"116","author":"Skarke","year":"2005","journal-title":"Pain"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/ALN.0b013e3181a105de","article-title":"Morphine-6\u00df-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans","volume":"110","author":"van Dorp","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/00003088-200443140-00003","article-title":"Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives","volume":"43","author":"Lotsch","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1111\/j.1472-8206.2010.00867.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/00000542-200404000-00042","article-title":"Genetic variability of mu-opioid receptor in an obstetric population","volume":"100","author":"Landau","year":"2004","journal-title":"Anesthesiology"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.2010.00867.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1472-8206.2010.00867.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:04:22Z","timestamp":1740499462000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.2010.00867.x"}},"subtitle":["Pharmacodynamics, pharmacokinetics of morphine in PACU"],"short-title":[],"issued":{"date-parts":[[2010,9,6]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.2010.00867.x","relation":{},"ISSN":["0767-3981"],"issn-type":[{"value":"0767-3981","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,6]]}}}